Tavernier Susan S, Beck Susan L, Clayton Margaret F, Pett Marjorie A, Berry Donna L
Saint Alphonsus Regional Medical Center, Boise, ID, USA.
Oncol Nurs Forum. 2011 May;38(3):319-29. doi: 10.1188/11.ONF.319-329.
PURPOSE/OBJECTIVES: To evaluate psychometric properties of an instrument designed to measure individualized health-related quality of life (HRQOL).
Repeated measures of self-reported quality of life.
An outpatient radiation therapy department in the western part of the United States.
86 adults with cancer receiving their first course of radiation therapy.
The Patient Generated Index (PGI), the National Comprehensive Cancer Network's Distress Thermometer (DT), and the European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire-Core-30 (QLQ-C30).
Convergent validity, responsiveness, sensitivity, and response shift.
PGI scores were inversely correlated with scores on the DT (r = -0.49, -0.55, -0.44; p < 0.001), as well as the role (r = 0.31, 0.4, 0.38; p < 0.01), emotional (r = 0.33, 0.41, 0.33; p < 0.01), social functioning (r = 0.27, 0.49, 0.42; p < 0.05), pain (r = -0.29, -0.39, -0.39; p < 0.01), and fatigue (r = -0.35, -0.25, -0.47; p < 0.05) QLQ-C30 subscales at all measurement times. The PGI was responsive to those reporting high or low DT scores (t = 4.42, 3.32, 2.9; p < 0.05). A small-to-moderate effect size was detected in those who had an increase (effect size = 0.51) or decrease (effect size = 0.38) in HRQOL over time. Participants reconceptualized HRQOL over time.
Data supported the PGI as a valid measure of individualized HRQOL.
The PGI potentially provides a more patient-centered measure of HRQOL in patients with cancer. Additional testing is needed in larger, more diverse groups.
目的/目标:评估一种旨在测量个体化健康相关生活质量(HRQOL)的工具的心理测量特性。
对自我报告的生活质量进行重复测量。
美国西部的一个门诊放疗科。
86名接受首次放疗疗程的成年癌症患者。
患者生成指数(PGI)、美国国立综合癌症网络的苦恼温度计(DT)以及欧洲癌症研究与治疗组织生活质量问卷核心30项(QLQ-C30)。
收敛效度、反应性、敏感性和反应偏移。
PGI得分与DT得分呈负相关(r = -0.49、-0.55、-0.44;p < 0.001),以及与角色(r = 0.31、0.4、0.38;p < 0.01)、情绪(r = 0.33、0.41、0.33;p < 0.01)、社会功能(r = 0.27、0.49、0.42;p < 0.05)、疼痛(r = -0.29、-0.39、-0.39;p < 0.01)和疲劳(r = -0.35、-0.25、-0.47;p < 0.05)的QLQ-C30子量表在所有测量时间均呈负相关。PGI对报告高或低DT得分的人有反应(t = 4.42、3.32、2.9;p < 0.05)。随着时间的推移,在HRQOL有所增加(效应量 = 0.51)或减少(效应量 = 0.38)的人群中检测到小到中等的效应量。参与者随着时间的推移重新概念化了HRQOL。
数据支持PGI作为个体化HRQOL的有效测量工具。
PGI可能为癌症患者提供一种更以患者为中心的HRQOL测量方法。需要在更大、更多样化的群体中进行进一步测试。